These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 36136066)
21. COVID-19 as a Trigger of Brain Autoimmunity. Gupta M; Weaver DF ACS Chem Neurosci; 2021 Jul; 12(14):2558-2561. PubMed ID: 34213312 [TBL] [Abstract][Full Text] [Related]
22. Case Report: Circulating Anti-SARS-CoV-2 Antibodies Do Not Cross-React With Pemphigus or Pemphigoid Autoantigens. Kasperkiewicz M; Bednarek M; Tukaj S Front Med (Lausanne); 2021; 8():807711. PubMed ID: 34988105 [TBL] [Abstract][Full Text] [Related]
23. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions? Karagöz IK; Munk MR; Kaya M; Rückert R; Yıldırım M; Karabaş L Exp Eye Res; 2021 Feb; 203():108433. PubMed ID: 33400927 [TBL] [Abstract][Full Text] [Related]
24. Impact of COVID-19 on thyroid gland functions with reference to Graves' disease: A systematic review. Vamshidhar IS; Rani SSS; Kalpana M; Gaur A; Umesh M; Ganji V; Saluja R; Taranikanti M; John NA J Family Med Prim Care; 2023 Sep; 12(9):1784-1789. PubMed ID: 38024874 [TBL] [Abstract][Full Text] [Related]
25. COVID-19 disease and autoimmune disorders: A mutual pathway. Al-Beltagi M; Saeed NK; Bediwy AS World J Methodol; 2022 Jul; 12(4):200-223. PubMed ID: 36159097 [TBL] [Abstract][Full Text] [Related]
26. Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2. Venkatakrishnan AJ; Kayal N; Anand P; Badley AD; Church GM; Soundararajan V Cell Death Discov; 2020; 6(1):96. PubMed ID: 33024578 [TBL] [Abstract][Full Text] [Related]
27. Molecular insights into onset of autoimmunity in SARS-CoV-2 infected patients. Laxminarayana D Rheumatol Autoimmun; 2022 Dec; 2(4):198-202. PubMed ID: 36714799 [TBL] [Abstract][Full Text] [Related]
28. Adaptive Immunity and the Risk of Autoreactivity in COVID-19. Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670 [TBL] [Abstract][Full Text] [Related]
29. Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies. Damoiseaux J; Dotan A; Fritzler MJ; Bogdanos DP; Meroni PL; Roggenbuck D; Goldman M; Landegren N; Bastard P; Shoenfeld Y; Conrad K Autoimmun Rev; 2022 Mar; 21(3):103012. PubMed ID: 34896650 [TBL] [Abstract][Full Text] [Related]
30. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection. Saheb Sharif-Askari N; Saheb Sharif-Askari F; Ahmed SBM; Hannawi S; Hamoudi R; Hamid Q; Halwani R Front Immunol; 2021; 12():686462. PubMed ID: 34276672 [TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 Gut-Targeted Epitopes: Sequence Similarity and Cross-Reactivity Join Together for Molecular Mimicry. Lerner A; Benzvi C; Vojdani A Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509576 [TBL] [Abstract][Full Text] [Related]
33. HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD. Deshmukh US; Sim DL; Dai C; Kannapell CJ; Gaskin F; Rajagopalan G; David CS; Fu SM J Autoimmun; 2011 Nov; 37(3):254-62. PubMed ID: 21868195 [TBL] [Abstract][Full Text] [Related]
34. Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications. Dalakas MC; Bitzogli K; Alexopoulos H Front Immunol; 2021; 12():627285. PubMed ID: 33679770 [No Abstract] [Full Text] [Related]
35. Is Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein a Potential Basis for Autoimmune Responses in Vaccinated and Naturally Infected Patients? Carnevale S; Giovanetti M; Benvenuto D; Ciccozzi M; Broccolo F Semin Thromb Hemost; 2023 Feb; 49(1):103-104. PubMed ID: 35021248 [No Abstract] [Full Text] [Related]
36. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection. Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM Elife; 2022 Jan; 11():. PubMed ID: 35072628 [TBL] [Abstract][Full Text] [Related]
37. COVID-19 coagulopathies: Human blood proteins mimic SARS-CoV-2 virus, vaccine proteins and bacterial co-infections inducing autoimmunity: Combinations of bacteria and SARS-CoV-2 synergize to induce autoantibodies targeting cardiolipin, cardiolipin-binding proteins, platelet factor 4, prothrombin, and coagulation factors. Root-Bernstein R Bioessays; 2021 Dec; 43(12):e2100158. PubMed ID: 34677872 [TBL] [Abstract][Full Text] [Related]
38. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. Lyons-Weiler J J Transl Autoimmun; 2020; 3():100051. PubMed ID: 32292901 [TBL] [Abstract][Full Text] [Related]